Cadmium regulates von Willebrand factor and occludin expression in glomerular endothelial cells of mice in a TNF-α-dependent manner

References

• Wei T, Jia J, Wada Y, et al. Dose dependent effects of cadmium on tumor angiogenesis. Oncotarget. 2017;8(27):44944–44959.
   Google Scholar
• Jarup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol. 2009;238:201–208.
   PubMed Web of Science ®Google Scholar
• Liu F, Wang B, Li L, et al. Low-dose cadmium upregulates VEGF expression in lung adenocarcinoma cells. Int J Environ Res Public Health. 2015;12:10508–10521.
   PubMed Web of Science ®Google Scholar
• Jing Y, Liu LZ, Jiang Y, et al. Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. Toxicol Sci. 2012;125:10–19.
   PubMed Web of Science ®Google Scholar
• Dong F, Guo F, Li L, et al. Cadmium induces vascular permeability via activation of the p38 MAPK pathway. Biochem Biophys Res Commun. 2014;450:447–452.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li L, Wang Y, et al. NF-kappaB signaling maintains the survival of cadmium-exposed human renal glomerular endothelial cells. Int J Mol Med. 2016;38:417–422.
   PubMed Web of Science ®Google Scholar
• Edwards JR, Prozialeck WC. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol. 2009;238:289–293.
   PubMed Web of Science ®Google Scholar
• Li L, Dong F, Xu D, et al. Short-term, low-dose cadmium exposure induces hyperpermeability in human renal glomerular endothelial cells. J Appl Toxicol. 2016;36:257–265.
   PubMed Web of Science ®Google Scholar
• Chen X, Li J, Cheng Z, et al. Low dose cadmium inhibits proliferation of human renal mesangial cells via activation of the JNK pathway. Int J Environ Res Public Health. 2016;13(10):990.
   Web of Science ®Google Scholar
• Dong F, Li L, Chen X, et al. Glomerular endothelial cell IQGAP2 and filtration barrier function. Kidney Int. 2016;89:1160–1161.
   PubMed Web of Science ®Google Scholar
• Du L, Dong F, Guo L, et al. Interleukin-1beta increases permeability and upregulates the expression of vascular endothelial-cadherin in human renal glomerular endothelial cells. Mol Med Rep. 2015;11:3708–3714.
   PubMed Web of Science ®Google Scholar
• Liu J, Yuan L, Molema G, et al. Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle. Blood. 2011;117:342–351.
   PubMed Web of Science ®Google Scholar
• Liu J, Kanki Y, Okada Y, et al. A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice. J Thromb Haemost. 2009;7:1384–1392.
   PubMed Web of Science ®Google Scholar
• Patel TV, Mittal BV, Keithi-Reddy SR, et al. Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. Nephron Clin Pract. 2008;110:c244–c250.
   PubMed Web of Science ®Google Scholar
• Shen L, Lu G, Dong N, et al. Von Willebrand factor, ADAMTS13 activity, TNF-alpha and their relationships in patients with chronic kidney disease. Exp Ther Med. 2012;3:530–534.
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Hu C, Ding G, et al. Albumin impairs renal tubular tight junctions via targeting the NLRP3 inflammasome. Am J Physiol Renal Physiol. 2015;308:F1012–F1019.
   PubMed Web of Science ®Google Scholar
• Lee SY, Shin JA, Kwon HM, et al. Renal ischemia-reperfusion injury causes intercalated cell-specific disruption of occludin in the collecting duct. Histochem Cell Biol. 2011;136:637–647.
   PubMed Web of Science ®Google Scholar
• Kuwabara H, Kokai Y, Kojima T, et al. Occludin regulates actin cytoskeleton in endothelial cells. Cell Struct Funct. 2001;26:109–116.
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu Q, Dong F, et al. Catalpol downregulates vascular endothelialcadherin expression and induces vascular hyperpermeability. Mol Med Rep. 2016;13:373–378.
   PubMed Web of Science ®Google Scholar
• Olszowski T, Baranowska-Bosiacka I, Gutowska I, et al. Pro-inflammatory properties of cadmium. Acta Biochim Pol. 2012;59:475–482.
   PubMed Web of Science ®Google Scholar
• Alghasham A, Salem TA, Meki AR. Effect of cadmium-polluted water on plasma levels of tumor necrosis factor-alpha, interleukin-6 and oxidative status biomarkers in rats: protective effect of curcumin. Food Chem Toxicol. 2013;59:160–164.
   PubMed Web of Science ®Google Scholar
• Li Y, Li L, Dong F, et al. Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction. Exp Ther Med. 2015;10:1743–1749.
   PubMed Web of Science ®Google Scholar
• Prozialeck WC, Edwards JR. Mechanisms of cadmium-induced proximal tubule injury: new insights with implications for biomonitoring and therapeutic interventions. J Pharmacol Exp Ther. 2012;343:2–12.
   PubMed Web of Science ®Google Scholar
• Mei H, Yao P, Wang S, et al. Chronic low-dose cadmium exposure impairs cutaneous wound healing with defective early inflammatory responses after skin injury. Toxicol Sci. 2017;159:327–338.
   PubMed Web of Science ®Google Scholar
• Dong F, Zhou X, Li C, et al. Dihydroartemisinin targets VEGFR2 via the NF-kappaB pathway in endothelial cells to inhibit angiogenesis. Cancer Biol Ther. 2014;15:1479–1488.
   PubMed Web of Science ®Google Scholar
• Liu J, Dong F, Hoh J. Loss of HtrA1-induced attenuation of TGF-β signaling in fibroblasts might not be the main mechanism of CARASIL pathogenesis. Proc Natl Acad Sci USA. 2015;112:E1693
   PubMed Web of Science ®Google Scholar
• Dong F, Cheng Y, Sun Q, et al. CD109 is specifically expressed in endothelial cells of cutaneous cavernous haemangioma. Histopathology. 2015;67:133–135.
   PubMed Web of Science ®Google Scholar
• Liu J, Kapron CM. Differential induction of MAP kinase signalling pathways by cadmium in primary cultures of mouse embryo limb bud cells. Reprod Toxicol. 2010;29:286–291.
   PubMed Web of Science ®Google Scholar
• Chen X, Li L, Liu F, et al. Cadmium induces glomerular endothelial cell-specific expression of complement factor H via the -1635 AP-1 binding site. JI. 2019;202:1210–1218.
   Google Scholar
• Kim KS, Lim HJ, Lim JS, et al. Curcumin ameliorates cadmium-induced nephrotoxicity in Sprague-Dawley rats. Food Chem Toxicol. 2018;114:34–40.
   PubMed Web of Science ®Google Scholar
• Donpunha W, Kukongviriyapan U, Sompamit K, et al. Protective effect of ascorbic acid on cadmium-induced hypertension and vascular dysfunction in mice. Biometals. 2011;24:105–115.
   PubMed Web of Science ®Google Scholar
• Shen R, Liu D, Hou C, et al. Protective effect of Potentilla anserina polysaccharide on cadmium-induced nephrotoxicity in vitro and in vivo. Food Funct. 2017;8:3636–3646.
   PubMed Web of Science ®Google Scholar
• Chen S, Liu G, Long M, et al. Alpha lipoic acid attenuates cadmium-induced nephrotoxicity via the mitochondrial apoptotic pathways in rat. J Inorg Biochem. 2018;184:19–26.
   PubMed Web of Science ®Google Scholar
• Trujillo J, Molina-Jijon E, Medina-Campos ON, et al. Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats. Toxicol Mech Methods. 2014;24:520–528.
   PubMed Web of Science ®Google Scholar
• Cummins PM. Occludin: one protein, many forms. Mol Cell Biol. 2012;32:242–250.
   PubMed Web of Science ®Google Scholar
• Wang X, Dong F, Wang F, et al. Low dose cadmium upregulates the expression of von Willebrand factor in endothelial cells. Toxicol Lett. 2018;290:46–54.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Qi R, Li L, et al. Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression. Biomed Pharmacother. 2018;99:313–318.
   PubMed Web of Science ®Google Scholar
• Bugnicourt JM, Roussel B, Tramier B, et al. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study. J Neurol Neurosurg Psychiatry. 2007;78:699–701.
   PubMed Web of Science ®Google Scholar
• Khaleghi M, Singletary LA, Kondragunta V, et al. Haemostatic markers are associated with measures of vascular disease in adults with hypertension. J Hum Hypertens. 2009;23:530–537.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao J, Zhang Y, et al. Kinetics of plasma von Willebrand factor in acute myocardial infarction patients: a meta-analysis. Oncotarget. 2017;8:90371–90379.
   PubMedGoogle Scholar
• Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008;117:1449–1459.
   PubMed Web of Science ®Google Scholar